BCC Group Thailand Ltd. established in 1980. by a group of medical professionals and scientists who hope to provide cutting-edge healthcare in Thailand. More than 300,000 people have been helped thus far, and they wish to advance artificial medicine's potential and quality anywhere else.
Panorama NIPT is a technology of screening test for detecting chromosomal abnormalities in the fetus directly from the mother's blood. This cutting-edge technology is developed in the United States. This groundbreaking approach is applicable from as early as the 9th week of pregnancy and boasts a remarkable accuracy rate exceeding 99.9%
Prenatal diagnosis involves the assessment of the structure and functionality of the developing fetus's organs within the mother's womb. The aim is to facilitate appropriate treatment, monitoring, and planning for a birth that. Genetic testing methods used for diagnosis encompass cytogenetic analysis : karyotyping, QF-PCR and chromosomal microarray testing (CMA)
Paternity testing, often referred to in Thai as "DNA testing," is a genetic examination used to establish the biological relationship between a father and child. It relies on genetic testing technology, or DNA analysis, to identify similarities or differences between the child and the alleged father. This examination is based on the fundamental principle that children inherit genetic material equally from both their mother and father.
65/17-18 Soi Vibhavadi Rangsit 16/6 Vibhavadi Rangsit Road Chomphon,Chatuchak, Bangkok. 10900
Tel. : 02-690-0063, 086-306-2084 090-907-4230
Fax : 02-690-0064
Email : info@bccgroup-thailand.com
